Duke study identifies SERINC2 as potential target for preventing brain metastasis
Start here
A peer-reviewed study from Mikhail Nikiforov's team at Duke University, published in Cell Reports in 2026, identifies SERINC2 as a potential intervention target for preventing brain metastasis. The findings suggest a new avenue for stopping cancer from spreading to the brain, a major cause of morbidity and mortality in patients with advanced disease. The work is early-stage laboratory research rather than a clinical result, and no therapeutic approach targeting SERINC2 has yet entered development or testing in patients. How the finding might translate into preventive treatment, and in which cancer types it would apply, remains open.
Written by a model from the reports · updated 4 hours ago
Coverage timeline
Follow the coverage to see the different angles.
- medicalxpress.comPickPathology research identifies potential new target for preventing brain metastasis
A peer-reviewed study by Mikhail Nikiforov's team at Duke University, published in Cell Reports (2026), identifies SERINC2 as a potential intervention target for preventing brain metastasis.
Heat trend for this story
Heat now 6·Peak in the comparable set 10 (Oct 28 00:00)·Change over 24h in the comparable set –·Participants now 1
Participants counted above, heat below. The trend compares only the participants observed in full throughout, so its set can be smaller than the heat figure itself. Move the pointer or click the chart for an hour's reading; the left and right arrow keys work too.